Contravisory Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-23
| Closed | -$11.3K | – | 439 |
|
|
2026
Q1 | $11.3K | Hold |
23
| – | – | ﹤0.01% | 342 |
|
|
2025
Q4 | $13.3K | Buy |
+23
| New | +$13K | ﹤0.01% | 323 |
|
|
2023
Q3 | – | Sell |
-817
| Closed | -$426K | – | 385 |
|
|
2023
Q2 | $426K | Hold |
817
| – | – | 0.11% | 131 |
|
|
2023
Q1 | $471K | Sell |
817
-16
| -2% | -$9.02K | 0.13% | 97 |
|
|
2022
Q4 | $459K | Buy |
833
+108
| +15% | +$57.2K | 0.13% | 98 |
|
|
2022
Q3 | $368K | Sell |
725
-15
| -2% | -$8.39K | 0.12% | 105 |
|
|
2022
Q2 | $402K | Buy |
740
+22
| +3% | +$12.1K | 0.13% | 100 |
|
|
2022
Q1 | $424K | Sell |
718
-9
| -1% | -$5.17K | 0.12% | 111 |
|
|
2021
Q4 | $485K | Sell |
727
-21
| -3% | -$13.1K | 0.13% | 110 |
|
|
2021
Q3 | $427K | Buy |
748
+26
| +4% | +$14.3K | 0.13% | 96 |
|
|
2021
Q2 | $364K | Sell |
722
-15,718
| -96% | -$7.42M | 0.11% | 132 |
|
|
2021
Q1 | $7.5M | Sell |
16,440
-994
| -6% | -$474K | 2.35% | 9 |
|
|
2020
Q4 | $8.12M | Sell |
17,434
-21
| -0.1% | -$9.85K | 2.52% | 7 |
|
|
2020
Q3 | $7.71M | Sell |
17,455
-167
| -0.9% | -$69K | 2.63% | 5 |
|
|
2020
Q2 | $6.12M | Buy |
17,622
+66
| +0.4% | +$22.1K | 2.25% | 8 |
|
|
2020
Q1 | $4.98M | Buy |
17,556
+159
| +0.9% | +$50.1K | 2.21% | 12 |
|
|
2019
Q4 | $5.65M | Buy |
17,397
+141
| +0.8% | +$42.8K | 2.07% | 13 |
|
|
2019
Q3 | $5.03M | Sell |
17,256
-183
| -1% | -$52.4K | 1.91% | 17 |
|
|
2019
Q2 | $5.12M | Sell |
17,439
-825
| -5% | -$227K | 1.98% | 17 |
|
|
2019
Q1 | $5M | Sell |
18,264
-712
| -4% | -$177K | 1.94% | 16 |
|
|
2018
Q4 | $4.25M | Sell |
18,976
-164
| -0.9% | -$38.5K | 1.83% | 22 |
|
|
2018
Q3 | $4.67M | Sell |
19,140
-653
| -3% | -$150K | 1.68% | 25 |
|
|
2018
Q2 | $4.1M | Buy |
+19,793
| New | +$4.2M | 1.5% | 37 |
|
|
2017
Q1 | – | Sell |
-16
| Closed | -$2K | – | 337 |
|
|
2016
Q4 | $2K | Hold |
16
| – | – | ﹤0.01% | 262 |
|
|
2016
Q3 | $3K | Hold |
16
| – | – | ﹤0.01% | 241 |
|
|
2016
Q2 | $2K | Hold |
16
| – | – | ﹤0.01% | 193 |
|
|
2016
Q1 | $2K | Hold |
16
| – | – | ﹤0.01% | 182 |
|
|
2015
Q4 | $2K | Buy |
+16
| New | +$2.13K | ﹤0.01% | 191 |
|
|
2013
Q3 | – | Sell |
-285
| Closed | -$24K | – | 136 |
|
|
2013
Q2 | $24K | Buy |
+285
| New | +$23.7K | 0.01% | 94 |
|
Other funds holding TMO
Contravisory Investment Management's TMO Position: Q2 2026 in Review
Contravisory Investment Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 23 shares — an estimated $11.3K sold.
Contravisory Investment Management first reported a position in TMO in Q2 2013 and held it in 29 quarters. The position peaked at $8.12M in Q4 2020. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Contravisory Investment Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
- Contravisory Investment Management sold 23 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.3K.
- Contravisory Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 29 quarters.
- Contravisory Investment Management's Thermo Fisher Scientific position peaked at $8.12M in Q4 2020.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.